CA
NZ
UK
AU
IND
US
Kairos Pharma, LTD. (NYSE American: KAPA) has announced a strategic collaboration with Bayer HealthCare Pharmaceuticals to further explore the therapeutic potential of its lead antibody, ENV-105 (carotuximab), in metastatic castration-resistant prostate cancer (mCRPC). This collaboration aims to bolster the treatment environment for prostate cancer, …
Hansa Biopharma AB's Q2 2026 earnings results showed a significant widening of losses, raising questions about its financial trajectory as it approaches a highly anticipated product launch. The company is focused on gearing up for entry into the market with its new product offering, …
Thermo Fisher Scientific Inc. (NYSE: TMO) is currently facing a slight share decline, with its stock falling 0.8% to $519.16 in today’s trading. The healthcare and life sciences giant is experiencing this drop despite favorable recent performance, illustrated by an 11.9% increase in share …
CVS Health Corporation (CVS) witnessed a decline of 1.1% in its stock price, closing at $109.39 amid concerns over its updated earnings outlook. Despite substantial gains earlier this year, with a 36.5% increase year-to-date and shares appreciating 78.82% over the past 52 weeks, the …
Healthcare Services Group Inc. (NASDAQ: HCSG) announced impressive financial results for the second quarter of 2026, reporting revenue of $470.8 million and diluted earnings per share (EPS) of $0.32, exceeding analyst estimates of $0.23. This performance underscores the strength of the company’s business model …
Healthcare Services Group, Inc. (NASDAQ: HCSG) reported its Q2 2026 earnings with an EPS of $0.32, exceeding analyst estimates of $0.23. This performance reflects effective management strategies within a challenging sector. Nevertheless, the stock experienced a decline of 4.4%, trading at $23.71 after the …
ICON Plc (NASDAQ: ICLR) faced a slight decline in its share price, dropping 0.5% to $166.62. For the quarter ending March 31, the company reported earnings per share of $2.50, surpassing analyst expectations of $2.47. Despite this positive earnings surprise, the shares have not …
Inspire Medical Systems (NYSE: INSP) confirmed that long‑time director Casey Tansey will step down from the board, ending an eighteen‑year tenure that began with the company’s 2007 Series A financing. Tansey’s retirement becomes effective July 30 2026 and he will not seek re‑election at …
Kairos Pharma, LTD. (NYSE American: KAPA) has announced a strategic collaboration with Bayer HealthCare Pharmaceuticals to further explore the therapeutic potential of its lead antibody, ENV-105 (carotuximab), in metastatic castration-resistant prostate cancer (mCRPC). This collaboration aims to bolster the treatment environment for prostate cancer, …
Becton Dickinson (NYSE: BDX) confirmed that its senior executive overseeing the Medical Essentials and BioPharma Systems segments will step down, with the departure slated for early October. Michael D. Market observers noted a modest movement in the stock following the announcement, reflecting typical investor …
Please wait processing your request...